2019 Annual Meeting | Division Chief Conversation

Date Thursday 05/09/19

Time 05:00 PM - 05:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Hubs (Navigating Your Career)

Director(s) Amy R. Brooks-Kayal, MD, FAAN

Topic(s) Experiential Learning Area, General Neurology

CME Available No CME available

Core Competencies Interpersonal and Communication Skills, Professionalism

Program Level Introductory

Program Tracks Academic

Recommended Audience Other

Program Materials Program Evaluations

Event Timeline
05:00 PM - 05:30 PM EDT	Speaker	Division Chief Conversation Amy R. Brooks-Kayal, MD, FAAN
05:00 PM - 05:30 PM EDT	Speaker	Division Chief Conversation Claire Henchcliffe, MD, PhD, FAAN

Faculty Disclosures
Amy R. Brooks-Kayal, MD, FAAN	Dr. Brooks-Kayal has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brooks-Kayal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Brooks-Kayal has or had stock in Johnson and Johnson. The institution of Dr. Brooks-Kayal has received research support from NINDS.
Claire Henchcliffe, MD, PhD, FAAN	Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar. Dr. Henchcliffe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Savanna. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meira GTx. Dr. Henchcliffe has or had stock in Axent Biosciences Inc. The institution of Dr. Henchcliffe has received research support from Weston Brain Institute. The institution of Dr. Henchcliffe has received research support from Blue Rock Therapeutics. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Parkinson Study Group. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Course director with AAN. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic Foundation. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Vertex. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ESGCT.

��ɫ��

��ɫ��